Dexur provides quality predictions and improvement reports for Hospitals to improve rankings in programs such as CMS Star Ratings, CMS VBP & CMS HRRP. Dexur predictions are based on CMS Medicare Claims that data Dexur is approved to access from CMS, CMS Published data, and Dexur algorithms.
Data behind is for subscribers.If you want to review your detailed readmissions & mortality report, including improvement opportunities, please email dexur@dexur.com.
Our predictions have proven to be accurate and beneficial to healthcare providers in the past. Here is what one of our Hospital customers said about Dexur: Diane Barnes, Director, Quality Resources at Parkview Health, said - "Dexur has been an integral partner in helping us elevate our quality and value programs. As most quality professionals know, monitoring quality programs is incredibly challenging, with extremely complex calculations, risk adjustments, and significant lags in data. Their enhanced algorithms simulate the impact of change of individual or multiple measures to program outcomes. Dexur's statistical expertise and advisory services bring it all together to guide meaningful and effective strategy".
HRRP & Mortality Forecast as of September 2023 | |||
---|---|---|---|
Forecast Year |
Measure Period |
Available Data Period |
Forecasted Data Period |
FY 2024 CMS HRRP, Star Rating & VBP |
July 1, 2019 to June 30, 2022 |
July 1, 2019 to June 1, 2022 |
Nil |
FY 2025 CMS HRRP, Star Rating & VBP |
July 1, 2020 to June 30, 2023 |
July 1, 2020 to June 1, 2022 |
July 1 2022 to June 30, 2023 (12 months) |
FY 2026 CMS HRRP, Star Rating & VBP |
July 1, 2021 to June 30, 2024 |
July 1, 2020 to June 1, 2022 |
July 1, 2022 to June 30, 2024 (24 months) |
Measure |
FY-2026 |
FY-2025 |
FY-2024 |
FY-2023 |
FY-2022 |
---|---|---|---|---|---|
READM-30-AMI |
July 1, 2021 to June 30, 2024 |
July 1, 2020 to June 30, 2023 |
July 1, 2019 to June 30, 2022 |
July 1, 2018 to June 30, 2021 |
July 1, 2017 to Dec 1, 2019 |
READM-30-CABG |
July 1, 2021 to June 30, 2024 |
July 1, 2020 to June 30, 2023 |
July 1, 2019 to June 30, 2022 |
July 1, 2018 to June 30, 2021 |
July 1, 2017 to Dec 1, 2019 |
READM-30-HF |
July 1, 2021 to June 30, 2024 |
July 1, 2020 to June 30, 2023 |
July 1, 2019 to June 30, 2022 |
July 1, 2018 to June 30, 2021 |
July 1, 2017 to Dec 1, 2019 |
READM-30-COPD |
July 1, 2021 to June 30, 2024 |
July 1, 2020 to June 30, 2023 |
July 1, 2019 to June 30, 2022 |
July 1, 2018 to June 30, 2021 |
July 1, 2017 to Dec 1, 2019 |
READM-30-PN |
July 1, 2021 to June 30, 2024 |
July 1, 2020 to June 30, 2023 |
July 1, 2019 to June 30, 2022 |
N/A |
July 1, 2017 to Dec 1, 2019 |
READM-30-HIP-KNEE |
July 1, 2021 to June 30, 2024 |
July 1, 2020 to June 30, 2023 |
July 1, 2019 to June 30, 2022 |
July 1, 2018 to June 30, 2021 |
July 1, 2017 to Dec 1, 2019 |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $141,501 |
17.32% | 15.6%
No |
#
10.07% | 10.1%
No |
19.24% | 19.1%
No |
#
18.69% | 19.6%
No |
#
14.57% | 15.8%
No |
9.05% | 4.6%
Yes ($141,501) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #10.26%|13.7% 10th percentile (13.8) |
3.07%|3.0% 50th percentile (2.9) |
10.43%|10.1% 10th percentile (9.8) |
#10.06%|11.3% ND |
#14.9%|16.1% 30th percentile (16.5) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $127,605 |
17.12% | 14.8%
No |
#
8.62% | 11.0%
No |
23.12% | 20.5%
Yes ($20,087) |
#
19.15% | 19.3%
No |
#
15.89% | 16.3%
NA |
10.2% | 4.7%
Yes ($107,518) |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #12.84%|13.7% 10th percentile (13.7) |
3.2%|2.8% 50th percentile (2.9) |
10.2%|9.9% 10th percentile (9.8) |
11.13%|10.9% ND |
16.14%|14.9% 70th percentile (14.9) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (Yes) | (No) | (Yes) | (Yes) | (No) |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (No) | (Yes) | (No) | (Yes) |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (Yes) | (No) | (Yes) | (No) | (Yes) |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
#
12.96% | 19.2%
NA |
#
3.12% | 20.4%
NA |
20.0% | 17.4%
NA |
NA
|
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#2.44%|8.0% 50th percentile (8.2) |
18.18%|12.4% ND |
#8.82%|14.9% 70th percentile (14.5) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
#
16.67% | 19.7%
NA |
24.24% | 21.8%
NA |
20.0% | 17.4%
NA |
NA
|
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#3.33%|8.0% 50th percentile (8.2) |
#10.34%|11.1% ND |
#13.64%|17.1% 30th percentile (17.1) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
23.19% | 20.0%
NA |
#
21.69% | 21.9%
NA |
#
11.9% | 15.8%
NA |
ND | NA
NA |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
9.26%|8.1% 50th percentile (8.2) |
#5.13%|12.0% ND |
#8.7%|13.6% 90th percentile (13.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
21.57% | 19.7%
NA |
#
17.5% | 20.3%
NA |
17.91% | 17.7%
NA |
ND | NA
NA |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#6.52%|8.1% 50th percentile (8.2) |
#8.64%|11.5% ND |
#9.33%|14.6% 70th percentile (14.9) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
#
19.05% | 19.2%
NA |
ND | NA
NA |
#
15.91% | 16.9%
NA |
NA
|
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#4.44%|8.0% 50th percentile (8.2) |
ND|ND ND |
16.67%|15.1% 50th percentile (15.4) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
NA
|
NA
|
ND | NA
NA |
ND | NA
NA |
#
9.38% | 16.6%
NA |
NA
|
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | NA |
NA |
ND|ND ND |
ND|ND ND |
22.22%|18.1% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
#
10.43% | 14.3%
No |
#
6.98% | 11.5%
No |
#
15.79% | 18.1%
No |
#
16.78% | 19.9%
No |
#
15.87% | 16.1%
No |
#
3.12% | 3.6%
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #7.93%|12.2% 50th percentile (12.4) |
#0.0%|2.6% 70th percentile (2.6) |
11.43%|10.4% 10th percentile (9.8) |
#15.79%|16.0% ND |
#16.15%|17.4% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
#
10.7% | 14.3%
No |
#
2.04% | 10.5%
No |
#
13.92% | 17.8%
No |
#
17.86% | 19.5%
No |
17.12% | 16.6%
NA |
#
2.58% | 3.5%
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #8.16%|13.1% 30th percentile (12.8) |
4.0%|2.6% 70th percentile (2.56) |
#8.13%|9.2% 30th percentile (8.8) |
16.18%|16.0% ND |
18.16%|17.5% 30th percentile (17.1) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (No) | (No) | (No) | (Yes) |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (No) | (Yes) | (No) | (Yes) |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (Yes) | (No) | (No) | (No) | (Yes) |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $12,836 |
ND | NA
No |
NA
|
#
20.0% | 20.1%
Yes ($933) |
#
18.6% | 21.2%
No |
ND | NA
No |
8.82% | 4.4%
Yes ($11,903) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
ND|ND ND |
#9.09%|10.6% ND |
ND|ND ND |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $6,792 |
ND | NA
No |
NA
|
ND | NA
No |
#
20.59% | 21.1%
No |
ND | NA
NA |
4.76% | 4.2%
Yes ($6,792) |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
ND|ND ND |
#6.67%|11.7% ND |
ND|ND ND |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | ||
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | |||
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | |||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $531,718 |
#
15.69% | 15.9%
Yes ($25,091) |
#
6.9% | 12.0%
No |
#
18.15% | 20.1%
Yes ($26,869) |
#
22.32% | 23.9%
Yes ($401,958) |
#
15.74% | 17.2%
Yes ($47,646) |
4.19% | 4.0%
Yes ($30,154) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #8.96%|13.8% 10th percentile (13.8) |
#1.52%|2.7% 70th percentile (2.6) |
#8.83%|9.6% 10th percentile (9.8) |
#9.89%|12.8% ND |
#16.14%|18.7% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $439,135 |
#
14.47% | 15.4%
Yes ($126,645) |
#
7.38% | 11.3%
No |
#
19.87% | 20.3%
Yes ($36,673) |
#
21.49% | 22.7%
Yes ($275,817) |
#
18.53% | 18.7%
NA |
4.59% | 3.8%
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #7.08%|12.3% 50th percentile (12.3) |
#1.52%|2.7% 70th percentile (2.56) |
#8.23%|9.3% 10th percentile (9.8) |
#10.62%|12.8% ND |
#15.78%|18.4% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (Yes) | (Yes) | (Yes) | (Yes) | (Yes) |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (Yes) | (Yes) | (Yes) | (Yes) |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (No) | (Yes) | (Yes) | (Yes) |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
#
15.87% | 19.8%
NA |
27.5% | 23.2%
NA |
20.78% | 17.5%
NA |
ND | NA
NA |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | NA |
NA |
9.09%|8.7% 30th percentile (8.8) |
#7.5%|11.9% ND |
#12.5%|16.1% 30th percentile (16.5) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
#
13.04% | 19.2%
NA |
ND | NA
NA |
#
13.33% | 16.6%
NA |
NA
|
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | NA |
NA |
#7.14%|8.7% 30th percentile (8.8) |
#8.0%|11.9% ND |
18.0%|16.1% 50th percentile (16.0) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
No |
NA
|
#
12.05% | 18.5%
No |
#
18.26% | 20.8%
No |
#
12.0% | 15.7%
No |
ND | NA
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#1.35%|7.1% 90th percentile (7.1) |
#10.0%|11.5% ND |
14.39%|13.4% 90th percentile (13.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
No |
NA
|
#
14.29% | 19.3%
No |
#
19.77% | 21.0%
No |
#
8.26% | 15.2%
NA |
ND | NA
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#0.0%|8.3% 50th percentile (8.2) |
#9.3%|11.0% ND |
#14.91%|15.3% 70th percentile (14.9) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (No) | (No) | (No) | |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | (No) | |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | (No) | |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
16.16% | 16.1%
No |
#
7.69% | 10.9%
No |
20.13% | 19.1%
No |
21.98% | 21.4%
No |
#
14.77% | 15.6%
No |
ND | NA
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #14.56%|15.2% 10th percentile (13.8) |
2.73%|2.4% 90th percentile (2.2) |
#7.8%|10.8% 10th percentile (9.8) |
#11.85%|13.7% ND |
#15.36%|17.7% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
#
14.76% | 14.8%
No |
#
2.82% | 10.0%
No |
#
18.58% | 19.0%
No |
22.32% | 21.0%
No |
#
13.46% | 15.3%
NA |
ND | NA
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #15.03%|15.7% 10th percentile (13.7) |
#1.32%|2.9% 50th percentile (2.9) |
10.43%|10.4% 10th percentile (9.8) |
#11.01%|13.4% ND |
#14.39%|18.4% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | (No) | (No) |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | (Yes) | (No) |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | (Yes) | (No) |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
#
10.08% | 12.4%
No |
#
8.71% | 10.0%
No |
ND | NA
No |
#
16.14% | 19.3%
No |
ND | NA
No |
NA
|
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #5.13%|9.7% 90th percentile (11.2) |
#0.27%|1.7% 90th percentile (2.2) |
ND|ND ND |
#5.04%|10.6% ND |
ND|ND ND |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
#
9.78% | 12.2%
No |
#
7.99% | 9.0%
No |
ND | NA
No |
#
15.43% | 19.0%
No |
ND | NA
NA |
NA
|
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #4.07%|10.5% 90th percentile (11.1) |
#0.84%|1.9% 90th percentile (2.2) |
ND|ND ND |
#5.13%|10.4% ND |
ND|ND ND |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | (No) | |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (No) | (No) | (No) | |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (No) | (No) | ||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $85,290 |
ND | NA
No |
NA
|
#
12.76% | 17.3%
No |
#
17.52% | 21.5%
No |
#
17.59% | 17.6%
Yes ($30,638) |
11.11% | 4.8%
Yes ($54,652) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#5.06%|6.6% 90th percentile (7.1) |
#9.68%|12.6% ND |
#16.42%|18.0% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $35,030 |
ND | NA
No |
NA
|
#
13.87% | 17.9%
No |
22.61% | 21.9%
Yes ($13,179) |
18.95% | 18.1%
NA |
7.41% | 4.4%
Yes ($21,851) |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#4.46%|7.4% 90th percentile (7.1) |
11.4%|11.4% ND |
#15.38%|19.4% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (Yes) | (Yes) | (No) | |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | (No) | |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | (No) | |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $116,673 |
ND | NA
No |
NA
|
#
15.97% | 19.1%
No |
#
16.52% | 20.8%
No |
#
9.48% | 14.9%
No |
4.43% | 4.2%
Yes ($116,673) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#3.39%|7.0% 90th percentile (7.1) |
13.89%|12.1% ND |
#15.53%|18.8% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
No |
NA
|
#
14.77% | 19.1%
No |
22.02% | 20.8%
No |
#
9.82% | 15.8%
NA |
#
3.52% | 3.8%
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#6.1%|7.7% 70th percentile (7.8) |
#10.2%|12.1% ND |
#13.77%|18.3% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (Yes) | (Yes) | (No) | |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (Yes) | (Yes) | (No) | |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (No) | (Yes) | (Yes) | |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $52,917 |
17.07% | 16.0%
Yes ($1,799) |
NA
|
22.16% | 21.3%
Yes ($25,337) |
#
18.18% | 21.5%
No |
17.6% | 17.3%
Yes ($25,781) |
3.88% | 3.8%
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | 15.56%|12.1% 70th percentile (11.9) |
NA |
#6.43%|8.3% 50th percentile (8.2) |
13.07%|12.6% ND |
#14.4%|15.6% 50th percentile (15.4) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $25,116 |
ND | 14.5%
No |
NA
|
21.48% | 20.9%
Yes ($13,909) |
#
21.74% | 22.1%
Yes ($11,207) |
19.72% | 17.6%
NA |
#
2.2% | 3.8%
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | 25.0%|12.9% 30th percentile (12.8) |
NA |
#5.45%|8.3% 50th percentile (8.2) |
14.84%|12.6% ND |
#10.9%|15.3% 70th percentile (14.9) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (Yes) | (No) | (Yes) | |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (Yes) | (Yes) | (Yes) | |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (Yes) | (Yes) | (Yes) | |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
NA
|
NA
|
NA
|
NA
|
NA
|
2.91% | 2.9%
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | NA |
NA |
NA |
NA |
NA |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
NA
|
NA
|
NA
|
NA
|
NA
|
3.37% | 3.1%
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | NA |
NA |
NA |
NA |
NA |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | |||||
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | |||||
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | |||||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $158,095 |
18.67% | 17.1%
Yes ($72,506) |
ND | NA
No |
#
18.86% | 20.1%
Yes ($13,243) |
23.18% | 23.0%
Yes ($71,424) |
#
15.19% | 16.6%
Yes ($922) |
#
2.92% | 3.7%
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #10.67%|13.1% 30th percentile (12.9) |
ND|ND ND |
#5.2%|8.6% 30th percentile (8.8) |
#9.18%|9.8% ND |
#16.67%|18.2% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $113,055 |
24.14% | 17.1%
Yes ($102,973) |
ND | NA
No |
#
15.07% | 19.6%
No |
#
20.18% | 21.3%
Yes ($9,166) |
#
13.57% | 16.3%
NA |
4.17% | 4.1%
Yes ($916) |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #9.87%|13.2% 30th percentile (12.8) |
ND|ND ND |
#5.74%|7.9% 70th percentile (7.8) |
#11.19%|11.6% ND |
#16.73%|19.9% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (No) | (No) | (Yes) | (Yes) |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (No) | (No) | (No) | (Yes) |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (Yes) | (No) | (No) | (Yes) |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $14,145 |
ND | NA
No |
NA
|
28.81% | 20.7%
Yes ($6,960) |
#
18.31% | 21.9%
Yes ($2,286) |
#
15.12% | 16.8%
Yes ($4,899) |
ND | NA
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#3.85%|7.9% 70th percentile (7.8) |
#4.55%|11.8% ND |
#8.42%|14.2% 70th percentile (14.5) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $5,740 |
ND | NA
No |
NA
|
22.5% | 20.0%
Yes ($1,509) |
#
20.69% | 21.7%
Yes ($4,231) |
18.18% | 17.4%
NA |
ND | NA
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#2.94%|7.3% 90th percentile (7.1) |
#5.56%|11.8% ND |
#11.27%|15.6% 50th percentile (16.0) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (Yes) | (Yes) | |||
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (No) | |||
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | |||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
29.27% | 21.1%
NA |
ND | NA
NA |
#
13.79% | 16.4%
NA |
ND | NA
NA |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#0.0%|7.7% 70th percentile (7.8) |
ND|ND ND |
#10.17%|15.7% 50th percentile (15.4) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
35.71% | 21.5%
NA |
ND | NA
NA |
#
15.91% | 16.9%
NA |
ND | NA
NA |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
ND|ND ND |
ND|ND ND |
#8.51%|16.6% 30th percentile (17.1) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
21.43% | 20.1%
NA |
#
18.52% | 21.9%
NA |
#
8.47% | 15.7%
NA |
NA
|
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | NA |
NA |
#6.98%|9.5% 10th percentile (9.8) |
13.89%|13.4% ND |
#5.17%|13.9% 70th percentile (14.5) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
NA |
NA
|
ND | NA
NA |
ND | NA
NA |
#
6.12% | 16.3%
NA |
NA
|
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | NA |
NA |
ND|ND ND |
#0.0%|13.2% ND |
#7.84%|16.1% 50th percentile (16.0) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | ||||||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $142,573 |
17.42% | 17.0%
Yes ($39,200) |
24.44% | 15.3%
Yes ($60,706) |
22.87% | 21.1%
Yes ($15,787) |
23.47% | 22.6%
Yes ($14,101) |
17.7% | 17.0%
No |
8.33% | 4.3%
Yes ($12,779) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #9.45%|12.4% 50th percentile (12.4) |
6.38%|3.9% 10th percentile (4.1) |
#5.92%|10.0% 10th percentile (9.8) |
#11.86%|13.5% ND |
16.94%|16.1% 30th percentile (16.5) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $85,345 |
15.75% | 15.5%
Yes ($21,724) |
19.44% | 13.4%
Yes ($44,996) |
#
18.7% | 19.7%
No |
#
20.72% | 20.9%
No |
20.55% | 17.7%
NA |
7.69% | 4.5%
Yes ($18,625) |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #8.42%|12.4% 50th percentile (12.3) |
10.81%|3.9% 10th percentile (4.0) |
#9.28%|9.9% 10th percentile (9.8) |
#9.95%|13.5% ND |
#14.63%|15.7% 50th percentile (16.0) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (No) | (Yes) | (No) | (No) |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (Yes) | (Yes) | (No) | (Yes) | (No) |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (Yes) | (Yes) | (No) | (Yes) | (No) |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $265 |
#
10.0% | 15.2%
No |
NA
|
#
19.05% | 19.5%
No |
#
17.65% | 22.0%
No |
21.21% | 17.1%
Yes ($265) |
NA
|
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #12.82%|13.1% 30th percentile (12.9) |
NA |
#0.0%|8.3% 50th percentile (8.2) |
#7.5%|11.3% ND |
24.32%|19.4% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
No |
NA
|
32.0% | NA
No |
#
18.18% | 21.5%
No |
ND | NA
NA |
NA
|
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
ND|ND ND |
#6.9%|10.6% ND |
24.0%|20.5% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | ||
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | ||
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | ||
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $357,928 |
18.02% | 15.9%
Yes ($6,962) |
ND | NA
No |
#
19.21% | 19.8%
No |
25.22% | 24.1%
Yes ($149,228) |
22.03% | 19.3%
Yes ($158,417) |
10.67% | 4.6%
Yes ($43,321) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #6.84%|12.1% 70th percentile (11.9) |
ND|ND ND |
#5.73%|7.1% 90th percentile (7.1) |
#7.81%|9.2% ND |
#14.22%|15.3% 50th percentile (15.4) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $99,917 |
14.14% | 14.1%
No |
ND | NA
No |
#
16.87% | 18.7%
No |
24.85% | 23.1%
Yes ($86,553) |
25.34% | 20.6%
NA |
9.76% | 4.4%
Yes ($13,364) |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #10.0%|11.4% 90th percentile (11.1) |
ND|ND ND |
#6.48%|6.6% 90th percentile (7.1) |
#10.49%|10.8% ND |
#15.18%|16.8% 30th percentile (17.1) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (Yes) | (Yes) | (Yes) | (No) |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (Yes) | (Yes) | (Yes) | (No) |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (Yes) | (Yes) | (Yes) | (No) |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
ND | NA
No |
NA
|
#
14.52% | 19.4%
No |
#
20.51% | 21.3%
No |
#
13.0% | 15.2%
No |
#
3.68% | 3.7%
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#4.81%|8.6% 30th percentile (8.8) |
#10.67%|11.8% ND |
#17.78%|18.4% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $130,926 |
ND | NA
No |
NA
|
#
19.35% | 20.5%
Yes ($6,665) |
24.48% | 21.8%
Yes ($7,692) |
#
15.94% | 16.8%
NA |
7.18% | 4.6%
Yes ($116,569) |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | ND|ND ND |
NA |
#9.41%|10.3% 10th percentile (9.8) |
12.12%|11.2% ND |
#17.0%|19.6% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (Yes) | (Yes) | (Yes) | |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (Yes) | (Yes) | (Yes) | |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (Yes) | (Yes) | (Yes) | |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $7,352 |
21.43% | 15.9%
Yes ($752) |
NA
|
#
16.52% | 19.3%
No |
#
16.38% | 20.2%
No |
#
12.45% | 16.6%
Yes ($6,600) |
#
3.31% | 3.7%
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | 21.88%|12.7% 30th percentile (12.9) |
NA |
9.26%|8.9% 30th percentile (8.8) |
#11.93%|13.3% ND |
#13.94%|19.0% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $15,977 |
28.0% | 15.8%
Yes ($4,795) |
NA
|
#
15.62% | 19.3%
No |
#
20.48% | 20.7%
No |
#
12.44% | 16.7%
NA |
6.06% | 4.2%
Yes ($11,182) |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | 15.38%|13.6% 10th percentile (13.7) |
NA |
14.06%|10.8% 10th percentile (9.8) |
#12.0%|13.9% ND |
#14.9%|19.0% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | (Yes) | |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (Yes) | (Yes) | |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (No) | (Yes) | (Yes) | |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $479,158 |
#
14.91% | 15.2%
No |
14.16% | 13.5%
Yes ($93,750) |
#
19.51% | 19.8%
No |
#
20.29% | 20.9%
No |
16.69% | 16.2%
No |
7.48% | 4.9%
Yes ($385,408) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #10.43%|13.4% 10th percentile (13.8) |
5.69%|4.7% 10th percentile (4.1) |
#9.09%|9.8% 10th percentile (9.8) |
15.68%|15.1% ND |
#12.74%|15.5% 50th percentile (15.4) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $497,529 |
#
14.79% | 15.2%
Yes ($41,278) |
15.94% | 13.8%
Yes ($120,347) |
21.81% | 20.3%
Yes ($25,661) |
22.39% | 21.3%
Yes ($7,190) |
17.2% | 16.6%
NA |
9.13% | 5.2%
Yes ($303,053) |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #10.36%|12.9% 30th percentile (12.8) |
#4.05%|4.7% 10th percentile (4.0) |
#6.38%|9.8% 10th percentile (9.8) |
#13.84%|15.1% ND |
#12.02%|14.5% 70th percentile (14.9) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (Yes) | (Yes) | (No) | (Yes) |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (Yes) | (No) | (No) | (Yes) |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (No) | (No) | (Yes) | (Yes) |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $9,410 |
#
8.48% | 13.7%
No |
NA
|
#
11.63% | 18.0%
No |
#
12.46% | 18.5%
No |
#
13.28% | 16.2%
No |
4.14% | 4.0%
Yes ($9,410) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #11.18%|14.7% 10th percentile (13.8) |
NA |
#6.54%|8.0% 50th percentile (8.2) |
#7.83%|11.3% ND |
#18.66%|19.2% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | - |
#
11.32% | 13.4%
No |
NA
|
#
18.52% | 19.7%
No |
#
12.5% | 19.6%
No |
#
12.94% | 16.1%
NA |
#
3.42% | 4.0%
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #11.81%|14.4% 10th percentile (13.7) |
NA |
11.02%|10.3% 10th percentile (9.8) |
#11.0%|12.3% ND |
#16.82%|18.2% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (Yes) | (No) | (No) | (No) | |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (Yes) | (Yes) | (Yes) | (No) | |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (Yes) | (Yes) | (Yes) | (No) | |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $128,541 |
#
15.22% | 16.3%
Yes ($2,858) |
NA
|
#
15.46% | 19.3%
No |
25.11% | 24.6%
Yes ($116,949) |
#
16.05% | 16.3%
No |
4.09% | 4.0%
Yes ($8,734) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | 18.42%|13.5% 10th percentile (13.8) |
NA |
#6.43%|8.2% 50th percentile (8.2) |
#11.85%|13.4% ND |
#14.9%|19.7% 10th percentile (18.2) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $89,303 |
#
15.38% | 15.9%
Yes ($19,707) |
NA
|
#
17.16% | 20.8%
Yes ($4,683) |
#
20.97% | 22.1%
Yes ($24,676) |
16.93% | 16.7%
NA |
4.79% | 4.3%
Yes ($40,237) |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | 15.66%|13.5% 10th percentile (13.7) |
NA |
#6.96%|9.0% 30th percentile (8.8) |
#12.9%|13.4% ND |
#13.49%|19.4% 10th percentile (19.07) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (No) | (Yes) | (No) | |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (Yes) | (No) | (Yes) | (No) | |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (Yes) | (Yes) | (No) | |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $31,597 |
#
14.71% | 16.1%
Yes ($2,754) |
NA
|
28.57% | 21.9%
Yes ($19,003) |
#
18.46% | 21.4%
No |
#
16.51% | 16.7%
Yes ($7,987) |
4.71% | 4.0%
Yes ($1,853) |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | 16.22%|12.6% 50th percentile (12.4) |
NA |
#4.11%|8.3% 50th percentile (8.2) |
#10.1%|13.0% ND |
#15.69%|16.9% 30th percentile (16.5) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $22,139 |
18.52% | 15.5%
Yes ($4,511) |
NA
|
30.65% | 22.2%
Yes ($17,628) |
#
19.2% | 20.8%
No |
17.01% | 16.8%
NA |
5.08% | 4.1%
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | 13.79%|12.4% 50th percentile (12.3) |
NA |
#7.41%|9.2% 30th percentile (8.8) |
#7.96%|10.0% ND |
#16.56%|16.9% 30th percentile (17.1) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (No) | (No) | |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (No) | (Yes) | (Yes) | |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (Yes) | (No) | (No) | (Yes) | (No) | |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $301,923 |
18.92% | 16.3%
Yes ($46,499) |
15.6% | 12.8%
Yes ($35,918) |
20.22% | 19.9%
No |
24.18% | 23.7%
Yes ($219,506) |
17.69% | 16.4%
No |
4.38% | 3.9%
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #11.04%|13.4% 10th percentile (13.8) |
#1.83%|3.1% 30th percentile (3.3) |
8.8%|8.7% 30th percentile (8.8) |
#10.59%|11.6% ND |
#14.2%|15.7% 50th percentile (15.4) |
NA |
2023 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $149,136 |
16.33% | 14.2%
No |
12.77% | 11.1%
No |
20.96% | 19.6%
No |
24.13% | 22.8%
Yes ($149,136) |
19.82% | 17.2%
NA |
4.35% | 4.0%
No |
2023 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #9.57%|13.8% 10th percentile (13.7) |
#1.01%|2.9% 50th percentile (2.9) |
#8.2%|8.6% 30th percentile (8.8) |
12.17%|12.0% ND |
#14.26%|15.7% 50th percentile (16.0) |
NA |
2024 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (Yes) | (Yes) | (Yes) |
2024 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2025 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (Yes) | (Yes) | (Yes) |
2025 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - | ||||||
2026 HRRP Dexur Observed | Dexur Risk Adjusted Rates Readmission Rates & Penalty | - | (No) | (No) | (No) | (Yes) | (Yes) | (Yes) |
2026 Dexur Observed | Dexur Risk Adjusted Mortality Rates & Percentile | - |
Measure & Time Periods | Total HRRP Impact | AMI | CABG | COPD | Heart Failure | Pneumonia | TKA |
---|---|---|---|---|---|---|---|
2022 HRRP Dexur Observed | CMS Risk Adjusted Readmission Rates & Penalty | $18,417 |
#
11.36% | 14.8%
No |
13.51% | 13.1%
Yes ($18,417) |
19.67% | 18.7%
No |
#
20.02% | 21.1%
No |
#
15.62% | 16.1%
No |
3.97% | 3.8%
No |
2022 Dexur Observed | CMS Risk Adjusted Mortality Rates & Percentile | - | #9.38%|12.8% 30th percentile (12.9) |
9.09%|4.5% 10th percentile (4.1) |
#7.95%|8.4% 50th percentile (8.2) |
#12.44%|12.8% |